Skip to main content
Fig. 3 | Reproductive Health

Fig. 3

From: Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population

Fig. 3

Likelihood of Using LARC (over SARC) Across Time Periods and Age Groups [1]. * Denotes statistical significance (P < 0.05) compared to the reference group of women 18–24 years old using LARC in the period January 2001 – June 2006. LARC: Long Acting Reversible Contraceptive, SARC: Short Acting Reversible Contraceptive. Note: The following covariates were also included in the model: region, plan type, comorbidities (i.e., venous thromboembolism, systemic lupus erythematosus, epilepsy, hypertension, obesity, asthma, diabetes, rheumatoid arthritis inflammatory bowel disease, and hypothyroidism), history of SARC use, history of LARC use, history of obstetrician/gynecologist visits, pregnancy history, abortion history, and nulliparous status

Back to article page

Reproductive Health

ISSN: 1742-4755